SPI1 and non-small cell lung carcinoma: Although, it is currently not possible to observe all patients over the same period of time, we additionally found a connection between a high expression of PU.1 in the blood of patients with NSCLC and an increased recurrence and metastases-free survival which emphasized the protective role of a high PU.1 expression in the periphery.